top of page

„T-FINDER: rapid production of ammunition in the battle againstcancer and infection”


Heidelberg, November 28th:

Towards CD4 cell therapy: with their T-FINDER platform, using a highly sensitive TCR signalling reporter, BioMed X Institute finds unknown antigens and validates TCRs.


The discussions run until late in the evening, networking, debates and simply enjoying the great atmosphere in the Urban Kitchen - perfect location for celebrating the BioRN network.


Комментарии


bottom of page